Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Anjeni Keswani"'
Publikováno v:
Allergy & Rhinology, Vol 9 (2018)
Introduction A 79-year-old woman with macular degeneration was referred to the Allergy/Immunology clinic for the evaluation of a potential allergy to anti-vascular endothelial growth factor (anti-VEGF) treatments. The patient developed urticaria and
Externí odkaz:
https://doaj.org/article/8a1228d690bc45fcbfe072b96608a5a8
Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm
Publikováno v:
American Journal of Rhinology & Allergy. 37:207-213
Background Chronic rhinosinusitis with nasal polyps (CRSwNP) has been traditionally managed with a combination of topical and systemic medical therapy as well as endoscopic sinus surgery. The emergence of biologic therapies that target specific aspec
Autor:
Rachel Peterson, Anjeni Keswani
Publikováno v:
American Journal of Rhinology & Allergy. 37:147-152
Background/Objective Multiple factors affect healthcare disparities in chronic rhinosinusitis (CRS) with and without nasal polyps. These factors include access to care, economic burdens to treatment, and differences in air pollution and air quality.
Autor:
Jamie A. Rosenthal, Michelle Premazzi Papa, Marta Sanz, Samuel Nicholes, Carissa S. Holmberg, Alberto Bosque, Anjeni Keswani, Richard Amdur, Rebecca M. Lynch, Natalia Soriano-Sarabia, Daniel Ein
Publikováno v:
Annals of Allergy, Asthma & Immunology.
Publikováno v:
Annals of Allergy, Asthma & Immunology. 128:223-225
Publikováno v:
American Journal of Rhinology & Allergy. 37:130-131
Publikováno v:
NEJM Evidence. 1
Autor:
John V. Bosso, Andrew A. White, Elina Jerschow, Tanya M. Laidlaw, Whitney W. Stevens, Joshua M. Levy, Seong H. Cho, Alan P. Baptist, Paloma Campo, Katherine N. Cahill, Anil Nanda, Kathleen M. Buchheit, Anjeni Keswani, Larry Borish
Publikováno v:
J Allergy Clin Immunol
Aspirin-exacerbated respiratory disease (AERD) is characterized by the clinical triad of chronic rhinosinusitis with nasal polyps, asthma, and an intolerance to medications that inhibit the cycloxgenase-1 enzyme. Patients with AERD on average have mo
Autor:
Seong H. Cho, Anil Nanda, Anjeni Keswani, Allen Adinoff, Fuad M. Baroody, Jonathan A. Bernstein, Alina Gherasim, Joseph K. Han, Jerald W. Koepke, Dennis K. Ledford, Amber N. Pepper, Carmen Rondón, Amy Schiffman, Martin Wagenmann, Paloma Campo
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:1215-1222.e4
Autor:
Paneez Khoury, Renganathan Srinivasan, Sujani Kakumanu, Sebastian Ochoa, Anjeni Keswani, Rachel Sparks, Nicholas L. Rider
Publikováno v:
J Allergy Clin Immunol Pract
Artificial and augmented intelligence (AI) and machine learning (ML) methods are expanding into the health care space. Big data are increasingly used in patient care applications, diagnostics, and treatment decisions in allergy and immunology. How th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e952747ffb5557c03fa0b21c560b6864
https://europepmc.org/articles/PMC9205719/
https://europepmc.org/articles/PMC9205719/